Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07466186

Resistance Training on Depression and Quality of Life in Type 1 Diabetic Women

Effect of Resistance Training on Depression and Quality of Life in Type 1 Diabetic Women

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
78 (estimated)
Sponsor
Middle East University · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Find out the effects of resistance training on depression, sleep quality, and quality of life in women with type 1 diabetes mellitus

Detailed description

Seventy-eight women aged 20 to 45 years with type 1 diabetes mellitus will be randomly assigned to either a resistance training group, which will receive both resistance and breathing exercises, or an active control group, which will receive breathing exercises only. The intervention will last for 12 weeks, with resistance exercises will be performed at moderate intensity. Outcomes will be assessed using the Beck Depression Inventory-II, the Pittsburgh Sleep Quality Index, and the Diabetes Quality of Life Questionnaire.

Conditions

Interventions

TypeNameDescription
OTHERResistance exercisesThe program will include seven exercises targeting major muscle groups: chest press, triceps extension, and shoulder front raise for the upper limbs; back extensions and abdominal crunches for the trunk; and leg press, leg curl, and calf raise for the lower limbs.
OTHERBreathing exercisesThe procedure will be first demonstrated and explained to each woman prior to the first session. Starting from a crook-lying position, participants will be guided to inhale through the nose for a count of four, hold their breath for another four counts, exhale slowly through the mouth over four counts, and then pause for an additional four counts before repeating the cycle.

Timeline

Start date
2026-03-18
Primary completion
2026-07-21
Completion
2026-07-28
First posted
2026-03-12
Last updated
2026-03-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07466186. Inclusion in this directory is not an endorsement.